152: A Cost-Effectiveness Model of Phosphate Binders for the Treatment of Hyperphosphatemia in Chronic Kidney Disease (CKD)

2010 ◽  
Vol 55 (4) ◽  
pp. B69
Author(s):  
Michael Keith ◽  
Michael Smyth ◽  
Rashad Carlton ◽  
Brian Meissner
Keyword(s):  
Chronic Kidney Disease ◽  
Cost Effectiveness ◽  
Kidney Disease ◽  
Phosphate Binders ◽  
Effectiveness Model

scholarly journals PUK6 A COST-EFFECTIVENESS MODEL FOR SECONDARY HYPERPARATHYROIDISM IN NON-DIALYSIS CHRONIC KIDNEY DISEASE

2019 ◽  
Vol 22 ◽  
pp. S913-S914
Author(s):  
M. Lilja ◽  
R. Lauppe ◽  
M. Intorcia ◽  
E.M. Dubois ◽  
P. Csomor ◽  
...  
Keyword(s):  
Chronic Kidney Disease ◽  
Cost Effectiveness ◽  
Kidney Disease ◽  
Secondary Hyperparathyroidism ◽  
Effectiveness Model

Phosphate binders in patients with chronic kidney disease: Between the new and the old.

2019 ◽  
pp. 2-3
Keyword(s):  
Chronic Kidney Disease ◽  
Kidney Disease ◽  
Estimated Glomerular Filtration Rate ◽  
Chronic Kidney Disease Stage ◽  
Disease Stage ◽  
Phosphate Binders ◽  
Advanced Chronic Kidney Disease ◽  
Phosphate Retention ◽  
Stage 4 ◽  
Dietary Phosphate

Impaired phosphate excretion by the kidney leads to Hyperphosphatemia. It is an independent predictor of cardiovascular disease and mortality in patients with advanced chronic kidney disease (stage 4 and 5) particularly in case of dialysis. Phosphate retention develops early in chronic kidney disease (CKD) due to the reduction in the filtered phosphate load. Overt hyperphosphatemia develops when the estimated glomerular filtration rate (eGFR) falls below 25 to 40 mL/min/1.73 m2. Hyperphosphatemia is typically managed with oral phosphate binders in conjunction with dietary phosphate restriction. These drugs aim to decrease serum phosphate by binding ingested phosphorus in the gastrointestinal tract and its transformation to non-absorbable complexes [1].

scholarly journals Cost-Effectiveness Analysis of Screening Chronic Kidney Disease in Iran

2019 ◽  
Author(s):  
Hamid Ravaghi ◽  
Mahdi Ebrahimnia ◽  
Ali Farzaneh ◽  
Zohreh Rostami ◽  
Mohammad Hasan Hashemi Madani
Keyword(s):  
Chronic Kidney Disease ◽  
Cost Effectiveness ◽  
Kidney Disease ◽  
Cost Effectiveness Analysis ◽  
Effectiveness Analysis
Sign in / Sign up

Export Citation Format

Share Document